RSI Oversold Bounce Stocks — Financial View · Healthcare
143 stocks match the RSI Oversold Bounce Stocks screen. Stocks whose 14-day RSI has just crossed back above 30 out of oversold territory — a potential reversal. Financial columns. Filtered to Healthcare. Data as of close · Checked
Filters2
1–100 of 143
Page of 2
| KLAC | KLA Corporation | $198.1B | 2.8% | 28.6% | 80.6% | 42.9% | 2.76 | 0.88 | 61.5% | 5.3% | 36.2% | 152.02 | -3.68% | 621K |
| INSM | Insmed Incorporated | $24.0B | — | -27.2% | -83.4% | -47.6% | 2.86 | 0.75 | 84.4% | -37.1% | -39.9% | 109.33 | -2.90% | 151K |
| MKSI | MKS Instruments | $13.3B | 0.5% | 4.9% | 14.7% | 8.0% | 1.14 | 0.85 | 47.0% | 15.7% | 10.1% | 196.42 | -2.65% | 97K |
| MDGL | Madrigal Pharmaceuticals, Inc. | $10.0B | — | -26.1% | -62.1% | -37.6% | 3.20 | 0.65 | — | -25.1% | -25.3% | 430.84 | +0.16% | 34K |
| ONTO | Onto Innovation | $9.4B | — | -0.1% | -0.2% | -0.2% | 9.73 | 0.00 | 49.7% | 13.2% | -0.4% | 191.27 | -5.02% | 44K |
| BKD | Brookdale Senior Living Inc. | $2.5B | — | -2.3% | — | -3.3% | 1.14 | -147.46 | 26.9% | 3.5% | -4.5% | 10.45 | +0.63% | 461K |
| TMDX | Transmedics Group, Inc. | $2.3B | 0.0% | 10.4% | 29.3% | 26.3% | 6.62 | 0.11 | 58.7% | 12.2% | 22.7% | 66.54 | +1.05% | 44K |
| RCUS | Arcus Biosciences, Inc. | $2.3B | — | -49.8% | -99.1% | -81.4% | 3.82 | 0.22 | — | — | — | 17.85 | -1.82% | 95K |
| URGN | Urogen Pharma Ltd. | $1.7B | — | -38.7% | — | — | 3.80 | -1.51 | 90.8% | -35.3% | -51.7% | 34.38 | +5.07% | 130K |
| SNDA | Sonida Senior Living, Inc. | $1.6B | — | -4.8% | -14.2% | -5.0% | 0.88 | 1.82 | — | 13.1% | -23.3% | 33.90 | -1.15% | 28K |
| NKTR | Nektar Therapeutics | $1.3B | — | -14.3% | -17.4% | -15.2% | 10.42 | 0.15 | — | — | — | 36.96 | -4.93% | 30K |
| RAPP | Rapport Therapeutics, Inc. | $1.2B | — | -29.9% | -32.4% | -32.4% | 15.72 | 0.09 | — | — | — | 25.10 | +0.32% | 57K |
| SNDX | Syndax Pharmaceuticals Inc | $1.2B | — | -30.2% | — | — | 4.69 | -41.32 | — | -61.7% | -72.3% | 13.07 | -4.11% | 217K |
| ATEC | Alphatec Holdings, Inc. | $1.1B | — | -10.9% | — | -16.0% | 2.36 | -237.62 | 71.3% | -3.6% | -10.3% | 7.31 | +3.54% | 1.2M |
| IRMD | Iradimed Corp | $1.0B | — | 19.8% | 22.5% | 22.5% | 8.99 | 0.14 | 75.5% | 32.3% | 26.8% | 79.41 | +3.50% | 18K |
| ORIC | Oric Pharmaceuticals, Inc. | $940M | — | -34.7% | -36.8% | -35.8% | 13.19 | 0.03 | — | — | — | 9.07 | -1.95% | 109K |
| INMD | Inmode Ltd. | $867M | — | 12.2% | 13.7% | 13.7% | 9.88 | 0.12 | 78.5% | 23.0% | 25.3% | 13.69 | +3.56% | 70K |
| LXRX | Lexicon Pharmaceuticals, Inc. | $641M | — | -24.4% | -35.0% | -27.0% | 13.37 | 0.29 | 99.1% | — | — | 1.44 | +0.70% | 155K |
| CADL | Candel Therapeutics, Inc. | $621M | — | -42.5% | -70.2% | -69.2% | 16.09 | 0.01 | — | — | — | 8.11 | -2.70% | 69K |
| AVR | Anteris Technologies Global Corp. | $562M | — | -38.0% | -41.2% | -41.2% | 14.20 | 0.08 | 75.0% | — | — | 5.77 | -8.63% | 204K |
| GYRE | GYRE THERAPEUTICS, INC. | $527M | — | -9.8% | -18.1% | -18.1% | 4.26 | 0.00 | 94.3% | -14.0% | -16.3% | 4.72 | +3.85% | 20K |
| FTH | Faeth Therapeutics, Inc. | $495M | — | — | — | — | 19.69 | 0.00 | — | — | — | 19.18 | +2.82% | 13K |
| MDXG | Mimedx Group, Inc. | $478M | — | -7.3% | -9.1% | -9.1% | 4.35 | 0.00 | 77.3% | -8.3% | -6.3% | 3.27 | -15.81% | 168K |
| ASMB | Assembly Biosciences, Inc. | $397M | — | -0.0% | -0.0% | -0.0% | 13.99 | 0.08 | — | -12.2% | -0.1% | 19.50 | -3.37% | 22K |
| ALLO | Allogene Therapeutics, Inc. | $373M | 0.0% | -30.1% | -37.9% | -37.9% | 10.72 | 0.26 | — | — | — | 1.08 | -8.09% | 398K |
| TECX | Tectonic Therapeutic, Inc. | $372M | 0.0% | -36.2% | -38.3% | -35.9% | 22.29 | 0.07 | — | — | — | 19.02 | -3.62% | 6K |
| KYTX | Kyverna Therapeutics, Inc. | $322M | — | -69.4% | -92.2% | -80.2% | 9.06 | 0.15 | — | — | — | 5.20 | -8.13% | 52K |
| IRD | Opus Genetics, Inc. | $309M | — | — | — | — | 12.19 | -2.72 | — | — | — | 3.71 | +0.81% | 81K |
| EIKN | Eikon Therapeutics, Inc. | $308M | — | — | — | — | 9.89 | 0.67 | — | — | — | 5.68 | +6.97% | 25K |
| MPLT | Maplight Therapeutics, Inc. | $308M | — | -62.4% | -66.0% | -66.0% | 16.52 | 0.06 | — | — | — | 6.77 | -10.80% | 17K |
| CGC | Canopy Growth | $288M | — | -21.3% | -34.1% | -25.3% | 3.04 | 0.35 | 25.2% | -54.9% | -80.0% | 0.68 | +4.07% | 74K |
| BIOA | Bioage Labs, Inc. | $267M | — | -23.8% | -25.2% | -25.2% | 17.19 | 0.00 | — | — | — | 5.82 | -1.02% | 53K |
| OCGN | Ocugen, Inc. | $247M | — | -65.9% | — | — | 0.80 | -0.10 | — | — | — | 0.73 | +2.84% | 134K |
| CABA | Cabaletta Bio, Inc. | $242M | — | -70.6% | -86.1% | -86.1% | 5.79 | 0.22 | — | — | — | 1.43 | -5.30% | 327K |
| UTMD | UTAH MEDICAL PRODUCTS INC | $224M | — | 8.4% | 8.6% | 8.6% | 48.62 | 0.00 | 57.9% | 28.4% | 29.0% | 70.39 | +3.02% | 2K |
| EVMN | Evommune, Inc. | $218M | — | -31.4% | -34.1% | -34.1% | 11.68 | 0.09 | — | — | — | 6.00 | -10.85% | 33K |
| IKT | Inhibikase Therapeutics, Inc. | $215M | — | -37.1% | -39.5% | -39.4% | 15.82 | 0.00 | — | — | — | 1.54 | -0.65% | 29K |
| UPB | Upstream Bio, Inc. | $183M | — | -55.7% | -57.8% | -57.8% | 27.99 | 0.04 | — | — | — | 3.35 | -1.76% | 85K |
| SION | Sionna Therapeutics, Inc. | $169M | — | -34.4% | -36.6% | -36.6% | 20.05 | 0.07 | — | — | — | 3.73 | -3.62% | 29K |
| NNNN | Anbio Biotechnology | $156M | — | 21.2% | 21.2% | — | 344.31 | 0.00 | 87.2% | 66.7% | 74.1% | 3.58 | +2.73% | 1K |
| MGNX | MACROGENICS INC | $149M | — | -4.2% | -34.0% | — | 2.96 | 7.06 | — | -24.3% | -8.7% | 2.33 | -3.51% | 67K |
| PRQR | ProQR Therapeutics N.V. | $138M | — | — | — | — | — | — | — | — | — | 1.31 | -5.76% | 34K |
| ZNTL | Zentalis Pharmaceuticals, Inc. | $131M | — | -64.8% | -97.1% | -97.1% | 4.82 | 0.50 | — | — | — | 1.83 | -6.63% | 94K |
| FHTX | Foghorn Therapeutics Inc. | $126M | — | -31.8% | — | — | 3.36 | 0.00 | — | — | — | 2.12 | +1.92% | 45K |
| AIRS | Airsculpt Technologies, Inc. | $120M | 24.6% | -6.1% | -11.2% | -7.9% | 0.79 | 0.42 | — | -8.4% | -7.8% | 1.67 | -5.11% | 70K |
| NERV | Minerva Neurosciences, Inc. | $112M | — | — | — | — | 20.14 | -0.04 | — | — | — | 2.35 | +1.29% | 17K |
| LFMD | Lifemd, Inc. | $111M | — | 0.3% | 2.5% | — | 0.90 | 2.00 | 86.1% | -14.7% | 0.1% | 2.30 | +0.00% | 36K |
| VYGR | Voyager Therapeutics, Inc. | $110M | 0.0% | -54.5% | -69.8% | -69.8% | 7.51 | 0.28 | — | — | — | 1.78 | +3.49% | 76K |
| NGEN | NERVGEN PHARMA CORP. | $107M | — | — | — | — | — | — | — | — | — | 1.34 | -2.19% | 21K |
| CRDL | Cardiol Therapeutics Inc. | $105M | — | — | — | — | — | — | — | — | — | 1.04 | -5.86% | 32K |
| MSLE | Satellos Bioscience Inc. | $100M | — | — | — | — | — | — | — | — | — | 6.46 | -4.22% | 40 |
| SEER | Seer, Inc. | $97M | 0.0% | -26.5% | -30.1% | -30.1% | 14.74 | 0.14 | 47.7% | — | — | 1.75 | +3.86% | 28K |
| NMRA | Neumora Therapeutics, Inc. | $93M | — | — | — | — | 4.50 | 1.19 | — | — | — | 0.49 | +34.69% | 172K |
| MIST | Milestone Pharmaceuticals Inc. | $91M | — | -46.3% | — | — | 8.13 | 3.25 | — | — | — | 0.73 | -1.65% | 18K |
| GNLX | GENELUX Corp | $90M | — | — | — | — | 2.39 | 0.63 | — | — | — | 2.00 | -4.31% | 8K |
| RLYB | Rallybio Corp | $85M | — | 28.1% | 29.0% | 29.0% | 28.87 | 0.04 | — | — | — | 15.77 | +0.64% | 1K |
| COYA | Coya Therapeutics, Inc. | $76M | — | -45.8% | -50.1% | — | 13.40 | 0.09 | — | — | — | 3.23 | -11.02% | 5K |
| MBOT | Microbot Medical Inc. | $70M | — | -22.3% | -23.7% | -23.7% | 18.56 | 0.00 | — | — | — | 1.04 | -4.59% | 26K |
| CGTX | COGNITION THERAPEUTICS INC | $67M | — | -43.1% | -50.8% | — | 7.03 | 0.18 | — | — | — | 0.71 | +1.15% | 2K |
| OPXS | Optex Systems Holdings Inc | $64M | — | 12.0% | 14.0% | — | 7.09 | 0.17 | 30.7% | 13.2% | 9.8% | 9.24 | +0.71% | 2K |
| QUCY | Quantum Cyber N.V. | $63M | — | -69.4% | -79.6% | — | 5.56 | 0.15 | 72.6% | — | — | 0.76 | -10.50% | 2K |
| CPIX | CUMBERLAND PHARMACEUTICALS INC | $63M | — | -17.4% | -62.6% | — | 0.96 | 2.62 | — | -24.1% | -27.4% | 4.23 | -10.00% | 2K |
| XBIT | XBiotech Inc. | $57M | — | -33.8% | -35.1% | -35.1% | 33.15 | 0.04 | — | — | — | 1.88 | -2.59% | 2K |
| CTOR | CITIUS ONCOLOGY, INC. | $56M | — | -41.1% | — | — | 0.73 | 1.78 | — | — | — | 0.60 | +9.49% | 1K |
| OSTX | OS Therapies Inc | $53M | — | — | — | — | 0.18 | -1.74 | — | — | — | 1.15 | -5.74% | 32K |
| XLO | Xilio Therapeutics, Inc. | $51M | — | -14.2% | -30.2% | -30.2% | 4.25 | 1.13 | — | -48.9% | -34.1% | 7.80 | -4.18% | 239 |
| IBIO | iBio, Inc. | $51M | — | -33.1% | -38.3% | -38.3% | 7.85 | 0.16 | — | — | — | 0.80 | +4.81% | 5K |
| GANX | Gain Therapeutics, Inc. | $49M | — | — | — | — | 4.36 | 0.03 | — | — | — | 1.13 | -0.88% | 6K |
| KLRS | Kalaris Therapeutics, Inc. | $48M | — | -44.5% | -76.7% | -76.7% | 10.98 | 0.73 | — | — | — | 2.00 | -1.72% | 1K |
| IMA | ImageneBio, Inc. | $46M | — | -34.5% | -36.9% | -36.9% | 21.47 | 0.07 | — | — | — | 4.03 | -2.89% | 103 |
| TIL | Instil Bio, Inc. | $45M | — | -15.3% | -28.2% | -28.2% | 21.67 | 0.84 | — | — | — | 6.60 | -2.94% | 150 |
| PTHS | Pelthos Therapeutics Inc. | $44M | — | -52.1% | — | — | 1.98 | -92.51 | 78.6% | — | — | 11.38 | +9.59% | 11K |
| DWTX | Dogwood Therapeutics, Inc. | $41M | — | -44.8% | -52.7% | -52.7% | 3.89 | 0.18 | — | — | — | 1.22 | -6.18% | 547 |
| INMB | Inmune Bio, Inc. | $38M | — | -68.6% | -90.4% | — | 4.04 | 0.74 | — | — | — | 1.38 | -4.84% | 16K |
| NYXH | Nyxoah SA | $38M | — | — | — | — | — | — | — | — | — | 0.88 | +1.14% | 351 |
| EXOZ | EXOZYMES INC. | $37M | — | — | — | — | 3.81 | 1.18 | — | — | — | 4.00 | -2.20% | 118 |
| ALDX | Aldeyra Therapeutics, Inc. | $35M | — | -48.5% | -60.8% | -43.3% | 4.91 | 0.40 | — | — | — | 0.58 | +4.30% | 60K |
| RPID | RAPID MICRO BIOSYSTEMS, INC. | $35M | — | -87.6% | — | — | 2.55 | 1.08 | — | — | — | 0.70 | -5.07% | 271 |
| PRPO | Precipio, Inc. | $32M | — | -1.7% | -2.5% | — | 1.77 | 0.02 | 43.3% | -5.6% | -1.3% | 17.79 | -2.36% | 821 |
| WOK | WORK Medical Technology Group LTD | $29M | — | -3.2% | -5.8% | — | 1.71 | 0.65 | 23.8% | — | -10.9% | 1.01 | -4.72% | 12 |
| MGX | Metagenomi Therapeutics, Inc. | $27M | — | -53.8% | -83.0% | -83.0% | 4.50 | 0.54 | — | — | — | 0.72 | -8.26% | 32K |
| CELU | Celularity Inc | $26M | — | -47.7% | — | — | 0.11 | -0.48 | 19.2% | — | — | 0.81 | +0.06% | 403 |
| NSPR | InspireMD, Inc. | $24M | — | — | — | — | 3.80 | 0.16 | 18.1% | — | — | 0.53 | +14.87% | 7K |
| DAIO | DATA I/O CORP | $24M | — | -36.2% | -75.2% | — | 1.93 | — | 50.6% | -43.7% | -50.1% | 2.35 | -1.67% | 182 |
| MIRA | MIRA PHARMACEUTICALS, INC. | $22M | — | — | — | — | 200.08 | 0.01 | — | — | — | 0.53 | -1.26% | 713 |
| ARAY | ACCURAY INC | $18M | — | -11.1% | — | -26.0% | 1.50 | 3.55 | 27.6% | -6.6% | -12.2% | 0.15 | +6.95% | 23K |
| LFWD | Lifeward Ltd. | $17M | — | -88.1% | — | — | 2.33 | 0.03 | 35.6% | — | — | 6.07 | +5.20% | 65 |
| CLIR | ClearSign Technologies Corp | $16M | — | -43.0% | -53.3% | — | 4.78 | 0.00 | 18.5% | — | -96.1% | 2.37 | +2.16% | 214 |
| ATYR | aTYR PHARMA INC | $16M | — | -87.1% | — | — | 5.12 | 0.06 | — | — | — | 6.38 | +29.15% | 5K |
| PIII | P3 Health Partners Inc. | $13M | — | -22.6% | — | -76.6% | 0.46 | 1.64 | — | -18.5% | -10.1% | 3.99 | -7.10% | 77 |
| LPCN | Lipocine Inc. | $12M | — | -49.7% | -54.4% | — | 11.48 | 0.04 | — | — | — | 1.44 | +0.00% | 6K |
| CLRB | Cellectar Biosciences, Inc. | $11M | — | -60.9% | -74.7% | — | 6.66 | 0.01 | — | — | — | 1.21 | +0.41% | 1K |
| TVRD | Tvardi Therapeutics, Inc. | $11M | 0.0% | — | — | — | 1.87 | 1.09 | — | — | — | 0.79 | -0.18% | 329 |
| PLSM | Pulsenmore Ltd. | $10M | — | — | — | — | — | — | — | — | — | 1.59 | -12.15% | 8 |
| PHIO | Phio Pharmaceuticals Corp. | $10M | — | -90.2% | — | — | 11.86 | 0.00 | — | — | — | 0.88 | +0.48% | 350 |
| INAB | IN8BIO, INC. | $9M | — | -85.8% | — | — | 8.21 | 0.18 | — | — | — | 0.96 | +6.83% | 113 |
| TOVX | Theriva Biologics, Inc. | $9M | — | -33.3% | -95.3% | — | 1.13 | 0.14 | — | — | — | 0.20 | +19.87% | 1.9M |
| PTN | PALATIN TECHNOLOGIES INC | $9M | — | -98.3% | — | — | 4.61 | 0.00 | — | -65.7% | -63.5% | 5.03 | -3.92% | 395 |
| LTRN | Lantern Pharma Inc. | $8M | — | — | — | — | 1.96 | -3.67 | — | — | — | 0.65 | +2.09% | 634 |
| NMTC | NEUROONE MEDICAL TECHNOLOGIES Corp | $8M | — | — | — | — | 2.84 | 0.64 | 55.6% | -83.4% | -78.6% | 0.90 | -3.91% | 100 |
Page of 2
Source: SEC EDGAR/XBRL (fundamentals, shares) · Databento EQUS.MINI (EOD prices) · multiples, ratios & technicals computed by tradmap. Financials: Trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year; revenue is the fiscal-year figure where quarterly revenue covers under half of it (typical for banks, insurers and REITs), and margins are taken on it. A company reporting in another currency is shown in ≈ USD: its figures convert at the Federal Reserve H.10 rate of its price date (FRED), and without a rate its multiples are blank. This product uses the FRED® API but is not endorsed or certified by the Federal Reserve Bank of St. Louis. Informational only — not financial advice.